Section Arrow
BLUE.NASDAQ
- bluebird bio
(Financial Status)
Quotes are at least 15-min delayed:2024/05/16 06:02 EDT
Last
 1.07
0 (0.00%)
Day High 
1.14 
Prev. Close
1.07 
1-M High
1.23 
Volume 
3.04M 
Bid
1.05
Ask
1.11
Day Low
1.06 
Open
1.1 
1-M Low
0.851 
Market Cap 
206.23M 
Currency USD 
P/E -- 
%Yield
10-SMA
20-SMA 0.97 
50-SMA 1.17 
52-W High 5.53 
52-W Low 0.851 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.63/-1.69
Enterprise Value
436.46M
Balance Sheet
Book Value Per Share
1.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.60M
Operating Revenue Per Share
0.11
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 06:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.